Brief: MyMD Pharmaceuticals Says Co Regained Compliance With Nasdaq Minimum Bid Price Requirement For Continued Listing

Q/C Technologies

05/03/2024 14:16

March 5 (Reuters) - MyMD Pharmaceuticals Inc  MYMD.O :
    * MYMD PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ
MINIMUM BID
PRICE REQUIREMENT FOR CONTINUED LISTING

Source text for Eikon:  ID:nBw6rJnkNa 
Further company coverage:  MYMD.O 

 ((Reuters.Briefs@thomsonreuters.com;))